Search Results for citation:"90 FR 11997"

Found 2 results
Skip to main content

Search Results: citation:"90 FR 11997"

  • Type:Notice
    Citation:90 FR 11997
    Reading Time:about a minute or two

    Patheon Pharmaceuticals Inc. has applied to the Drug Enforcement Administration to become a registered bulk manufacturer of certain controlled substances. The company plans to use these substances as Active Pharmaceutical Ingredients in FDA-approved medications. Anybody interested can submit comments or objections electronically by May 12, 2025, through the Federal eRulemaking Portal. Requests for a hearing regarding this application are also due by the same date.

    Simple Explanation

    Patheon Pharmaceuticals wants permission to make special medicines that need strict rules, and people can say what they think about this plan until May 12, 2025.

  • Type:Notice
    Citation:90 FR 11997
    Reading Time:about a minute or two

    Fisher Clinical Services, Inc. has applied to the Drug Enforcement Administration to be registered as an importer of certain controlled substances. The purpose of this registration is solely for use in clinical trials, and not for the commercial sale of the substances. The public can submit comments or request a hearing about this application until April 14, 2025. Comments must be submitted electronically, and hearings can be requested in writing, with specific addresses provided for these submissions.

    Simple Explanation

    Fisher Clinical Services wants permission from the government to bring special medicines into the country, but only to use them for testing, not selling. People have time until April 14, 2025, to tell the government what they think about this or ask for a chat about it.